請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47416完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 蕭世烜(Shih-Hsuan Hsiao) | |
| dc.contributor.author | Li-Shin Wu | en |
| dc.contributor.author | 吳立信 | zh_TW |
| dc.date.accessioned | 2021-06-15T05:58:51Z | - |
| dc.date.available | 2013-08-24 | |
| dc.date.copyright | 2010-08-24 | |
| dc.date.issued | 2010 | |
| dc.date.submitted | 2010-08-16 | |
| dc.identifier.citation | References
1 A. M. Abdel Nour, D. Ringot, J. L. Gueant, and A. Chango, 'Folate Receptor and Human Reduced Folate Carrier Expression in Hepg2 Cell Line Exposed to Fumonisin B1 and Folate Deficiency', Carcinogenesis, 28/11 (2007), pp. 2291-2297. 2 A. Alvaro, R. Rosales, L. Masana, and J. C. Vallve, 'Polyunsaturated Fatty Acids Down-Regulate in Vitro Expression of the Key Intestinal Cholesterol Absorption Protein Npc1l1: No Effect of Monounsaturated nor Saturated Fatty Acids', J Nutr Biochem, 21/6 (2010), pp. 518-525. 3 J. D. Bailly, G. Benard, J. Y. Jouglar, S. Durand, and P. Guerre, 'Toxicity of Fusarium Moniliforme Culture Material Containing Known Levels of Fumonisin B1 in Ducks', Toxicology, 163/1 (2001), pp. 11-22. 4 A. J. Bermudez, D. R. Ledoux, J. R. Turk, and G. E. Rottinghaus, 'The Chronic Effects of Fusarium Moniliforme Culture Material, Containing Known Levels of Fumonisin B1, in Turkeys', Avian Dis, 40/1 (1996), pp. 231-235. 5 M. Bertolotti, M. Del Puppo, C. Gabbi, F. Corna, L. Carulli, E. Pellegrini, L. Zambianchi, C. Anzivino, M. Ricchi, P. Loria, M. G. Kienle, and N. Carulli, 'Correlation between Plasma Levels of 7alpha-Hydroxy-4-Cholesten-3-One and Cholesterol 7alpha-Hydroxylation Rates in Vivo in Hyperlipidemic Patients', Steroids, 73/11 (2008), pp. 1197-1202. 6 S. Bouhet, and I. P. Oswald, 'The Intestine as a Possible Target for Fumonisin Toxicity', Mol Nutr Food Res, 51/8 (2007), pp. 925-931. 7 T. P. Brown, G. E. Rottinghaus, and M. E. Williams, 'Fumonisin Mycotoxicosis in Broilers: Performance and Pathology', Avian Dis, 36/2 (1992), pp. 450-454. 8 L. B. Bullerman, A. Bianchini, M. A. Hanna, L. S. Jackson, J. Jablonski, and D. Ryu, 'Reduction of Fumonisin B1 in Corn Grits by Single-Screw Extrusion', J Agric Food Chem, 56/7 (2008), pp. 2400-2405. 9 F. Caballero, A. Fernandez, A. M. De Lacy, J. C. Fernandez-Checa, J. Caballeria, and C. Garcia-Ruiz, 'Enhanced Free Cholesterol, Srebp-2 and Star Expression in Human Nash', J Hepatol, 50/4 (2009), pp. 789-796. 10 M. Castells, A. J. Ramos, V. Sanchis, and S. Marin, 'Reduction of Fumonisin B1 in Extruded Corn Breakfast Cereals with Salt, Malt and Sugar in Their Formulation', Food Addit Contam Part A Chem Anal Control Expo Risk Assess, 26/4 (2009), pp. 512-517. 11 'Center for Food Safety and Applied Nutrition, Fumonisin Levels in Human Foods and Animal Feeds', US Food and Drug Administration, (2001) < http://www.cfsan.fda.gov/ >. 12 Y. Cetin, and L. B. Bullerman, 'Cytotoxicity of Fusarium Mycotoxins to Mammalian Cell Cultures as Determined by the Mtt Bioassay', Food Chem Toxicol, 43/5 (2005), pp. 755-764. 13 V. Charlton-Menys, and P. N. Durrington, 'Human Cholesterol Metabolism and Therapeutic Molecules', Exp Physiol, 93/1 (2008), pp. 27-42. 14 F. S. Chu, and G. Y. Li, 'Simultaneous Occurrence of Fumonisin B1 and Other Mycotoxins in Moldy Corn Collected from the People's Republic of China in Regions with High Incidences of Esophageal Cancer', Appl Environ Microbiol, 60/3 (1994), pp. 847-852. 15 S. Dasgupta, M. Yanagisawa, K. Krishnamurthy, S. S. Liour, and R. K. Yu, 'Tumor Necrosis Factor-Alpha up-Regulates Glucuronosyltransferase Gene Expression in Human Brain Endothelial Cells and Promotes T-Cell Adhesion', J Neurosci Res, 85/5 (2007), pp. 1086-1094. 16 D. E. Diaz, The Mycotoxin Blue Book (Nottingham, U.K.: Nottingham University Press, 2005). 17 M. B. Doko, and A. Visconti, 'Occurrence of Fumonisins B1 and B2 in Corn and Corn-Based Human Foodstuffs in Italy', Food Addit Contam, 11/4 (1994), pp. 433-439. 18 A. M. Domijan, M. Peraica, K. Markov, and R. Fuchs, 'Urine Ochratoxin a and Sphinganine/Sphingosine Ratio in Residents of the Endemic Nephropathy Area in Croatia', Arh Hig Rada Toksikol, 60/4 (2009), pp. 387-393. 19 Paul N. Durrington, Hyperlipidaemia : Diagnosis and Management (London: Hodder Arnold, 2007). 20 M. F. Dutton, 'Fumonisins, Mycotoxins of Increasing Importance: Their Nature and Their Effects', Pharmacol Ther, 70/2 (1996), pp. 137-161. 21 Y. Espada, R. Ruiz de Gopegui, C. Cuadradas, and F. J. Cabanes, 'Fumonisin Mycotoxicosis in Broilers: Plasma Proteins and Coagulation Modifications', Avian Dis, 41/1 (1997), pp. 73-79. 22 J. Gelineau-van Waes, L. Starr, J. Maddox, F. Aleman, K. A. Voss, J. Wilberding, and R. T. Riley, 'Maternal Fumonisin Exposure and Risk for Neural Tube Defects: Mechanisms in an in Vivo Mouse Model', Birth Defects Res A Clin Mol Teratol, 73/7 (2005), pp. 487-497. 23 Walter J. Glenn, Scott Lowe, and Joshua Maher, Microsoft Exchange Server 2007 Administrator's Companion. 2nd edn (Redmond, WA: Microsoft Press, 2008), pp. xxvi, 746 p. 24 M. Goldfinger, E. L. Laviad, R. Hadar, M. Shmuel, A. Dagan, H. Park, A. H. Merrill, Jr., I. Ringel, A. H. Futerman, and B. Tirosh, 'De Novo Ceramide Synthesis Is Required for N-Linked Glycosylation in Plasma Cells', J Immunol, 182/11 (2009), pp. 7038-7047. 25 Y. Y. Gong, L. Torres-Sanchez, L. Lopez-Carrillo, J. H. Peng, A. E. Sutcliffe, K. L. White, H. U. Humpf, P. C. Turner, and C. P. Wild, 'Association between Tortilla Consumption and Human Urinary Fumonisin B1 Levels in a Mexican Population', Cancer Epidemiol Biomarkers Prev, 17/3 (2008), pp. 688-694. 26 D. J. Gordon, J. L. Probstfield, R. J. Garrison, J. D. Neaton, W. P. Castelli, J. D. Knoke, D. R. Jacobs, Jr., S. Bangdiwala, and H. A. Tyroler, 'High-Density Lipoprotein Cholesterol and Cardiovascular Disease. Four Prospective American Studies', Circulation, 79/1 (1989), pp. 8-15. 27 L. R. Harrison, B. M. Colvin, J. T. Greene, L. E. Newman, and J. R. Cole, Jr., 'Pulmonary Edema and Hydrothorax in Swine Produced by Fumonisin B1, a Toxic Metabolite of Fusarium Moniliforme', J Vet Diagn Invest, 2/3 (1990), pp. 217-221. 28 W. M. Haschek, L. A. Gumprecht, G. Smith, M. E. Tumbleson, and P. D. Constable, 'Fumonisin Toxicosis in Swine: An Overview of Porcine Pulmonary Edema and Current Perspectives', Environ Health Perspect, 109 Suppl 2 (2001), pp. 251-257. 29 M. H. Henry, R. D. Wyatt, and O. J. Fletchert, 'The Toxicity of Purified Fumonisin B1 in Broiler Chicks', Poult Sci, 79/10 (2000), pp. 1378-1384. 30 K. Hirano, C. Ikegami, K. Tsujii, Z. Zhang, F. Matsuura, Y. Nakagawa-Toyama, M. Koseki, D. Masuda, T. Maruyama, I. Shimomura, Y. Ueda, and S. Yamashita, 'Probucol Enhances the Expression of Human Hepatic Scavenger Receptor Class B Type I, Possibly through a Species-Specific Mechanism', Arterioscler Thromb Vasc Biol, 25/11 (2005), pp. 2422-2427. 31 P. I. Ho, D. Ashline, S. Dhitavat, D. Ortiz, S. C. Collins, T. B. Shea, and E. Rogers, 'Folate Deprivation Induces Neurodegeneration: Roles of Oxidative Stress and Increased Homocysteine', Neurobiol Dis, 14/1 (2003), pp. 32-42. 32 S. C. Hong, S. P. Zhao, and Z. H. Wu, 'Effect of Probucol on Hdl Metabolism and Class B Type I Scavenger Receptor (Sr-Bi) Expression in the Liver of Hypercholesterolemic Rabbits', Int J Cardiol, 115/1 (2007), pp. 29-35. 33 M. A. Hossain, M. Tsujita, F. J. Gonzalez, and S. Yokoyama, 'Effects of Fibrate Drugs on Expression of Abca1 and Hdl Biogenesis in Hepatocytes', J Cardiovasc Pharmacol, 51/3 (2008), pp. 258-266. 34 L. B. Hu, T. Zhang, Z. M. Yang, W. Zhou, and Z. Q. Shi, 'Inhibition of Fengycins on the Production of Fumonisin B1 from Fusarium Verticillioides', Lett Appl Microbiol, 48/1 (2009), pp. 84-89. 35 J. Huff, 'Iarc Monographs, Industry Influence, and Upgrading, Downgrading, and under-Grading Chemicals: A Personal Point of View. International Agency for Research on Cancer', Int J Occup Environ Health, 8/3 (2002), pp. 249-270. 36 M. Ishikawa, Y. Iwasaki, S. Yatoh, T. Kato, S. Kumadaki, N. Inoue, T. Yamamoto, T. Matsuzaka, Y. Nakagawa, N. Yahagi, K. Kobayashi, A. Takahashi, N. Yamada, and H. Shimano, 'Cholesterol Accumulation and Diabetes in Pancreatic Beta-Cell-Specific Srebp-2 Transgenic Mice: A New Model for Lipotoxicity', J Lipid Res, 49/12 (2008), pp. 2524-2534. 37 T. Javed, R. M. Bunte, M. A. Dombrink-Kurtzman, J. L. Richard, G. A. Bennett, L. M. Cote, and W. B. Buck, 'Comparative Pathologic Changes in Broiler Chicks on Feed Amended with Fusarium Proliferatum Culture Material or Purified Fumonisin B1 and Moniliformin', Mycopathologia, 159/4 (2005), pp. 553-564. 38 N. B. Javitt, 'Hep G2 Cells as a Resource for Metabolic Studies: Lipoprotein, Cholesterol, and Bile Acids', FASEB J, 4/2 (1990), pp. 161-168. 39 V. S. Kamanna, and M. L. Kashyap, 'Mechanism of Action of Niacin', Am J Cardiol, 101/8A (2008), pp. 20B-26B. 40 W. B. Kannel, J. D. Neaton, D. Wentworth, H. E. Thomas, J. Stamler, S. B. Hulley, and M. O. Kjelsberg, 'Overall and Coronary Heart Disease Mortality Rates in Relation to Major Risk Factors in 325,348 Men Screened for the Mrfit. Multiple Risk Factor Intervention Trial', Am Heart J, 112/4 (1986), pp. 825-836. 41 H. K. Kim, S. G. Cho, J. H. Kim, T. K. Doan, Q. S. Hu, R. Ulhaq, E. K. Song, and T. R. Yoon, 'Mevinolin Enhances Osteogenic Genes (Alp, Type I Collagen and Osteocalcin), Cd44, Cd47 and Cd51 Expression During Osteogenic Differentiation', Life Sci, 84/9-10 (2009), pp. 290-295. 42 M. Kobayashi, I. Chisaki, K. Narumi, K. Hidaka, T. Kagawa, S. Itagaki, T. Hirano, and K. Iseki, 'Association between Risk of Myopathy and Cholesterol-Lowering Effect: A Comparison of All Statins', Life Sci, 82/17-18 (2008), pp. 969-975. 43 G. Kohut, A. L. Adam, B. Fazekas, and L. Hornok, 'N-Starvation Stress Induced Fum Gene Expression and Fumonisin Production Is Mediated Via the Hog-Type Mapk Pathway in Fusarium Proliferatum', Int J Food Microbiol, 130/1 (2009), pp. 65-69. 44 S. Kovacic, S. Pepeljnjak, Z. Petrinec, and M. S. Klaric, 'Fumonisin B1 Neurotoxicity in Young Carp (Cyprinus Carpio L.)', Arh Hig Rada Toksikol, 60/4 (2009), pp. 419-426. 45 M. Krieger, 'Scavenger Receptor Class B Type I Is a Multiligand Hdl Receptor That Influences Diverse Physiologic Systems', J Clin Invest, 108/6 (2001), pp. 793-797. 46 N. P. Kriek, T. S. Kellerman, and W. F. Marasas, 'A Comparative Study of the Toxicity of Fusarium Verticillioides (= F. Moniliforme) to Horses, Primates, Pigs, Sheep and Rats', Onderstepoort J Vet Res, 48/2 (1981), pp. 129-131. 47 M. J. Ladu, C. Reardon, L. Van Eldik, A. M. Fagan, G. Bu, D. Holtzman, and G. S. Getz, 'Lipoproteins in the Central Nervous System', Ann N Y Acad Sci, 903 (2000), pp. 167-175. 48 D. R. Ledoux, T. P. Brown, T. S. Weibking, and G. E. Rottinghaus, 'Fumonisin Toxicity in Broiler Chicks', J Vet Diagn Invest, 4/3 (1992), pp. 330-333. 49 R. G. Lee, M. C. Willingham, M. A. Davis, K. A. Skinner, and L. L. Rudel, 'Differential Expression of Acat1 and Acat2 among Cells within Liver, Intestine, Kidney, and Adrenal of Nonhuman Primates', J Lipid Res, 41/12 (2000), pp. 1991-2001. 50 Y. G. Lee, J. Lee, and J. Y. Cho, 'Cell-Permeable Ceramides Act as Novel Regulators of U937 Cell-Cell Adhesion Mediated by Cd29, Cd98, and Cd147', Immunobiology, 215/4 (2010), pp. 294-303. 51 E. Levy, S. Spahis, D. Sinnett, N. Peretti, F. Maupas-Schwalm, E. Delvin, M. Lambert, and M. A. Lavoie, 'Intestinal Cholesterol Transport Proteins: An Update and Beyond', Curr Opin Lipidol, 18/3 (2007), pp. 310-318. 52 J. Lindenbaum, and B. J. Nath, 'Megaloblastic Anaemia and Neutrophil Hypersegmentation', Br J Haematol, 44/3 (1980), pp. 511-513. 53 'The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in Incidence of Coronary Heart Disease', JAMA, 251/3 (1984), pp. 351-364. 54 'The Lipid Research Clinics Coronary Primary Prevention Trial Results. Ii. The Relationship of Reduction in Incidence of Coronary Heart Disease to Cholesterol Lowering', JAMA, 251/3 (1984), pp. 365-374. 55 N. Lu, Y. Li, H. Qin, Y. L. Zhang, and C. H. Sun, 'Gossypin up-Regulates Ldl Receptor through Activation of Erk Pathway: A Signaling Mechanism for the Hypocholesterolemic Effect', J Agric Food Chem, 56/23 (2008), pp. 11526-11532. 56 M. Manzoor, and J. Runcie, 'Folate-Responsive Neuropathy: Report of 10 Cases', Br Med J, 1/6019 (1976), pp. 1176-1178. 57 W. F. Marasas, T. S. Kellerman, W. C. Gelderblom, J. A. Coetzer, P. G. Thiel, and J. J. van der Lugt, 'Leukoencephalomalacia in a Horse Induced by Fumonisin B1 Isolated from Fusarium Moniliforme', Onderstepoort J Vet Res, 55/4 (1988), pp. 197-203. 58 W. F. Marasas, R. T. Riley, K. A. Hendricks, V. L. Stevens, T. W. Sadler, J. Gelineau-van Waes, S. A. Missmer, J. Cabrera, O. Torres, W. C. Gelderblom, J. Allegood, C. Martinez, J. Maddox, J. D. Miller, L. Starr, M. C. Sullards, A. V. Roman, K. A. Voss, E. Wang, and A. H. Merrill, Jr., 'Fumonisins Disrupt Sphingolipid Metabolism, Folate Transport, and Neural Tube Development in Embryo Culture and in Vivo: A Potential Risk Factor for Human Neural Tube Defects among Populations Consuming Fumonisin-Contaminated Maize', J Nutr, 134/4 (2004), pp. 711-716. 59 H. Marina Martins, I. Almeida, M. F. Marques, and M. M. Guerra, 'Fumonisins and Deoxynivalenol in Corn-Based Food Products in Portugal', Food Chem Toxicol, 46/7 (2008), pp. 2585-2587. 60 J. Mayne, T. Dewpura, A. Raymond, M. Cousins, A. Chaplin, K. A. Lahey, S. A. Lahaye, M. Mbikay, T. C. Ooi, and M. Chretien, 'Plasma Pcsk9 Levels Are Significantly Modified by Statins and Fibrates in Humans', Lipids Health Dis, 7 (2008), pp. 22. 61 A. H. Merrill, Jr., E. M. Schmelz, D. L. Dillehay, S. Spiegel, J. A. Shayman, J. J. Schroeder, R. T. Riley, K. A. Voss, and E. Wang, 'Sphingolipids--the Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology', Toxicol Appl Pharmacol, 142/1 (1997), pp. 208-225. 62 A. H. Merrill, Jr., M. C. Sullards, E. Wang, K. A. Voss, and R. T. Riley, 'Sphingolipid Metabolism: Roles in Signal Transduction and Disruption by Fumonisins', Environ Health Perspect, 109 Suppl 2 (2001), pp. 283-289. 63 A. H. Merrill, Jr., E. Wang, T. R. Vales, E. R. Smith, J. J. Schroeder, D. S. Menaldino, C. Alexander, H. M. Crane, J. Xia, D. C. Liotta, F. I. Meredith, and R. T. Riley, 'Fumonisin Toxicity and Sphingolipid Biosynthesis', Adv Exp Med Biol, 392 (1996), pp. 297-306. 64 W. L. Miller, 'Androgen Synthesis in Adrenarche', Rev Endocr Metab Disord, 10/1 (2009), pp. 3-17. 65 S. A. Missmer, L. Suarez, M. Felkner, E. Wang, A. H. Merrill, Jr., K. J. Rothman, and K. A. Hendricks, 'Exposure to Fumonisins and the Occurrence of Neural Tube Defects Along the Texas-Mexico Border', Environ Health Perspect, 114/2 (2006), pp. 237-241. 66 V. Modur, G. A. Zimmerman, S. M. Prescott, and T. M. McIntyre, 'Endothelial Cell Inflammatory Responses to Tumor Necrosis Factor Alpha. Ceramide-Dependent and -Independent Mitogen-Activated Protein Kinase Cascades', J Biol Chem, 271/22 (1996), pp. 13094-13102. 67 Robert J. Moffatt, and Bryant A. Stamford, Lipid Metabolism and Health (Boca Raton, FL: CRC/Taylor & Francis, 2006). 68 J. M. Mogensen, K. F. Nielsen, R. A. Samson, J. C. Frisvad, and U. Thrane, 'Effect of Temperature and Water Activity on the Production of Fumonisins by Aspergillus Niger and Different Fusarium Species', BMC Microbiol, 9 (2009), pp. 281. 69 S. A. Mousavi, K. E. Berge, and T. P. Leren, 'The Unique Role of Proprotein Convertase Subtilisin/Kexin 9 in Cholesterol Homeostasis', J Intern Med, 266/6 (2009), pp. 507-519. 70 P. J. Mullen, B. Luscher, H. Scharnagl, S. Krahenbuhl, and K. Brecht, 'Effect of Simvastatin on Cholesterol Metabolism in C2c12 Myotubes and Hepg2 Cells, and Consequences for Statin-Induced Myopathy', Biochem Pharmacol, 79/8 (2010), pp. 1200-1209. 71 S. Nemoto, M. Nakamura, Y. Osawa, S. Kono, Y. Itoh, Y. Okano, T. Murate, A. Hara, H. Ueda, Y. Nozawa, and Y. Banno, 'Sphingosine Kinase Isoforms Regulate Oxaliplatin Sensitivity of Human Colon Cancer Cells through Ceramide Accumulation and Akt Activation', J Biol Chem, 284/16 (2009), pp. 10422-10432. 72 W. P. Norred, R. D. Plattner, R. F. Vesonder, C. W. Bacon, and K. A. Voss, 'Effects of Selected Secondary Metabolites of Fusarium Moniliforme on Unscheduled Synthesis of DNA by Rat Primary Hepatocytes', Food Chem Toxicol, 30/3 (1992), pp. 233-237. 73 R. B. Orsi, P. Dilkin, J. G. Xavier, S. Aquino, L. O. Rocha, and B. Correa, 'Acute Toxicity of a Single Gavage Dose of Fumonisin B1 in Rabbits', Chem Biol Interact, 179/2-3 (2009), pp. 351-355. 74 G. D. Osweiler, P. F. Ross, T. M. Wilson, P. E. Nelson, S. T. Witte, T. L. Carson, L. G. Rice, and H. A. Nelson, 'Characterization of an Epizootic of Pulmonary Edema in Swine Associated with Fumonisin in Corn Screenings', J Vet Diagn Invest, 4/1 (1992), pp. 53-59. 75 Alessandra Pani, and Sandra Dessi, Cell Growth and Cholesterol Esters, Molecular Biology Intelligence Unit. (New York: Kluwer Academic/Plenum, 2004). 76 D. K. Perry, and Y. A. Hannun, 'The Role of Ceramide in Cell Signaling', Biochim Biophys Acta, 1436/1-2 (1998), pp. 233-243. 77 E. I. Posse de Chaves, 'Sphingolipids in Apoptosis, Survival and Regeneration in the Nervous System', Biochim Biophys Acta, 1758/12 (2006), pp. 1995-2015. 78 D. B. Prelusky, H. L. Trenholm, B. A. Rotter, J. D. Miller, M. E. Savard, J. M. Yeung, and P. M. Scott, 'Biological Fate of Fumonisin B1 in Food-Producing Animals', Adv Exp Med Biol, 392 (1996), pp. 265-278. 79 D. B. Prelusky, H. L. Trenholm, and M. E. Savard, 'Pharmacokinetic Fate of 14c-Labelled Fumonisin B1 in Swine', Nat Toxins, 2/2 (1994), pp. 73-80. 80 D. J. Rader, and A. Daugherty, 'Translating Molecular Discoveries into New Therapies for Atherosclerosis', Nature, 451/7181 (2008), pp. 904-913. 81 'Report on Meetings of Expert Committees and Study Groups—Evaluation of Certain Mycotoxins', WHO, (2002) <http://www.who.int/gb/ebwha/pdf_files/EB110/eeb1106.pdf>. 82 J. Z. Reza, M. Doosti, M. Salehipour, M. Packnejad, M. Mojarrad, and M. Heidari, 'Modulation Peroxisome Proliferators Activated Receptor Alpha (Ppar Alpha) and Acyl Coenzyme A: Cholesterol Acyltransferase1 (Acat1) Gene Expression by Fatty Acids in Foam Cell', Lipids Health Dis, 8 (2009), pp. 38. 83 J. P. Rheeder, W. F. Marasas, and H. F. Vismer, 'Production of Fumonisin Analogs by Fusarium Species', Appl Environ Microbiol, 68/5 (2002), pp. 2101-2105. 84 P. F. Ross, L. G. Rice, R. D. Plattner, G. D. Osweiler, T. M. Wilson, D. L. Owens, H. A. Nelson, and J. L. Richard, 'Concentrations of Fumonisin B1 in Feeds Associated with Animal Health Problems', Mycopathologia, 114/3 (1991), pp. 129-135. 85 B. A. Rotter, B. K. Thompson, D. B. Prelusky, H. L. Trenholm, B. Stewart, J. D. Miller, and M. E. Savard, 'Response of Growing Swine to Dietary Exposure to Pure Fumonisin B1 During an Eight-Week Period: Growth and Clinical Parameters', Nat Toxins, 4/1 (1996), pp. 42-50. 86 J. E. Schjoth, A. Visconti, and L. Sundheim, 'Fumonisins in Maize in Relation to Climate, Planting Time and Hybrids in Two Agroecological Zones in Zambia', Mycopathologia, 167/4 (2009), pp. 209-219. 87 G. S. Shephard, P. G. Thiel, E. W. Sydenham, J. F. Alberts, and W. C. Gelderblom, 'Fate of a Single Dose of the 14c-Labelled Mycotoxin, Fumonisin B1, in Rats', Toxicon, 30/7 (1992), pp. 768-770. 88 J. M. Soriano, L. Gonzalez, and A. I. Catala, 'Mechanism of Action of Sphingolipids and Their Metabolites in the Toxicity of Fumonisin B1', Prog Lipid Res, 44/6 (2005), pp. 345-356. 89 D. Tardieu, J. D. Bailly, F. Skiba, F. Grosjean, and P. Guerre, 'Toxicokinetics of Fumonisin B1 in Turkey Poults and Tissue Persistence after Exposure to a Diet Containing the Maximum European Tolerance for Fumonisins in Avian Feeds', Food Chem Toxicol, 46/9 (2008), pp. 3213-3218. 90 M. G. Theumer, A. G. Lopez, M. P. Aoki, M. C. Canepa, and H. R. Rubinstein, 'Subchronic Mycotoxicoses in Rats. Histopathological Changes and Modulation of the Sphinganine to Sphingosine (Sa/So) Ratio Imbalance Induced by Fusarium Verticillioides Culture Material, Due to the Coexistence of Aflatoxin B1 in the Diet', Food Chem Toxicol, 46/3 (2008), pp. 967-977. 91 G. S. Tint, B. Dayal, A. K. Batta, S. Shefer, T. Joanen, L. McNease, and G. Salen, 'Biliary Bile Acids, Bile Alcohols, and Sterols of Alligator Mississippiensis', J Lipid Res, 21/1 (1980), pp. 110-117. 92 W. H. Tolleson, L. H. Couch, W. B. Melchior, Jr., G. R. Jenkins, M. Muskhelishvili, L. Muskhelishvili, L. J. McGarrity, O. Domon, S. M. Morris, and P. C. Howard, 'Fumonisin B1 Induces Apoptosis in Cultured Human Keratinocytes through Sphinganine Accumulation and Ceramide Depletion', Int J Oncol, 14/5 (1999), pp. 833-843. 93 'Toxins Derived from Fusarium Moniliforme: Fumonisins B1 and B2 and Fusarin C', IARC Monogr Eval Carcinog Risks Hum, 56 (1993), pp. 445-466. 94 T. C. Tseng, and C. Y. Liu, 'Natural Occurrence of Fumonisins B(1) and B(2) in Domestic Maize of Taiwan', J Agric Food Chem, 47/11 (1999), pp. 4799-4801. 95 ———, 'Occurrence of Fumonisin B1 and B2 in Corn-Based Foodstuffs in Taiwan Market', Mycopathologia, 137/1 (1997), pp. 57-61. 96 C. Vanchieri, 'Iarc Publishes Data on Worldwide Cancer Cases. International Agency for Research on Cancer', J Natl Cancer Inst, 85/13 (1993), pp. 1028-1029. 97 K. A. Voss, C. W. Bacon, W. P. Norred, R. E. Chapin, W. J. Chamberlain, R. D. Plattner, and F. I. Meredith, 'Studies on the Reproductive Effects of Fusarium Moniliforme Culture Material in Rats and the Biodistribution of [14c] Fumonisin B1 in Pregnant Rats', Nat Toxins, 4/1 (1996), pp. 24-33. 98 D. K. Vudathala, D. B. Prelusky, M. Ayroud, H. L. Trenholm, and J. D. Miller, 'Pharmacokinetic Fate and Pathological Effects of 14c-Fumonisin B1 in Laying Hens', Nat Toxins, 2/2 (1994), pp. 81-88. 99 T. S. Weibking, D. R. Ledoux, A. J. Bermudez, J. R. Turk, G. E. Rottinghaus, E. Wang, and A. H. Merrill, Jr., 'Effects of Feeding Fusarium Moniliforme Culture Material, Containing Known Levels of Fumonisin B1, on the Young Broiler Chick', Poult Sci, 72/3 (1993), pp. 456-466. 100 T. S. Weibking, D. R. Ledoux, T. P. Brown, and G. E. Rottinghaus, 'Fumonisin Toxicity in Turkey Poults', J Vet Diagn Invest, 5/1 (1993), pp. 75-83. 101 Eric P. Widmaier, Hershel Raff, Kevin T. Strang, and Arthur J. Vander, Vander's Human Physiology : The Mechanisms of Body Function (Boston: McGraw-Hill, 2006). 102 P. W. Wilson, R. B. D'Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel, 'Prediction of Coronary Heart Disease Using Risk Factor Categories', Circulation, 97/18 (1998), pp. 1837-1847. 103 Philip A. Wood, How Fat Works (Cambridge, Mass.: Harvard University Press, 2006). 104 C. A. Wu, M. Tsujita, M. Hayashi, and S. Yokoyama, 'Probucol Inactivates Abca1 in the Plasma Membrane with Respect to Its Mediation of Apolipoprotein Binding and High Density Lipoprotein Assembly and to Its Proteolytic Degradation', J Biol Chem, 279/29 (2004), pp. 30168-30174. 105 H. Xiao, and C. S. Yang, 'Combination Regimen with Statins and Nsaids: A Promising Strategy for Cancer Chemoprevention', Int J Cancer, 123/5 (2008), pp. 983-990. 106 C. Xin, W. Yan-Fu, H. Ping, G. Jing, W. Jing-Jing, M. Chun-Li, L. Wei, and C. Bei, 'Study of the Insulin Signaling Pathways in the Regulation of Acat1 Expression in Cultured Macrophages', Cell Biol Int, 33/5 (2009), pp. 602-606. 107 J. Zhu, M. Liu, R. H. Kennedy, and S. J. Liu, 'Tnf-Alpha-Induced Impairment of Mitochondrial Integrity and Apoptosis Mediated by Caspase-8 in Adult Ventricular Myocytes', Cytokine, 34/1-2 (2006), pp. 96-105. 108 沈永紹, 獸醫實驗診斷學提要. 5 edn (台灣: 施弘國, 2004). | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47416 | - |
| dc.description.abstract | 伏馬鐮孢毒素B1 (Fumonisin B1) 是一種黴菌毒素，主要是由經常汙染玉米的串珠鐮刀菌屬 (Fusarium verticillioides) 黴菌產生，許多文獻顯示，伏馬鐮孢毒素B1會造成許多動物種的高膽固醇血症，而這機制目前尚不清楚。在本研究中，主要的目標是藉由降膽固醇藥物與伏馬鐮孢毒素B1於人類肝癌細胞株 (HepG2)中之交互作用，從中找出伏馬鐮孢毒素B1導致高膽固醇血症的細胞性機制；另一方面則從豬場飼料及血液樣本找出伏馬鐮孢毒素B1與高膽固醇血症之間關聯性的野外證據。實驗結果顯示，伏馬鐮孢毒素B1會增加HepG2細胞內的膽固醇濃度，而伏馬鐮孢毒素B1也會抑制低密度脂蛋白受體 (LDL-receptor) 及輔酶A:膽固醇乙醯轉移酶 (acyl-CoA:cholesterol acyltransferase; ACAT) 的mRNA表現量，若是要以藥物控制伏馬鐮孢毒素B1導致的高膽固醇血症，Probucol可能是一種有效的藥物。另外，結果也顯示，目前台灣豬用飼料是有受到伏馬鐮孢毒素B1汙染，且檢測豬隻的血中膽固醇含量，也證實豬隻是有高膽固醇血症的情形。對於兩者之間的關連性，則需要排除其他干擾因子，才能進一步的找出關聯性的直接證據。 | zh_TW |
| dc.description.abstract | Fumonisin B1 (FB1) is a member of mycotoxins, produced by Fusarium verticillioides (formerly F. moniliforme), a common fungal contaminant of corn. FB1 causes hypercholesterolemia in many animal species. The mechanism of FB1-induced hypercholesterolemia is unknown. We aimed to investigate the cellular mechanism of FB1-induced hypercholesterolemia by exploring agonistic hypocholesterolemic agents in HepG2 cells, and to search for a field evidence on the link between dietary FB1 and hypercholesterolemia endemic in swine population. The results indicated that FB1 induced increases in cellular concentration of cholesterol. At the moment, FB1 inhibited expression of LDL-receptor and ACAT mRNATo control the hypercholesterolemia induced by FB1, probucol might be effective. In Taiwan, FB1 contamination was noted in pig feed. Serum cholesterol was higher than the normal range of pigs. Ruling out other factors of hypercholesterolemia might be helpful to conclude a direct link between dietary FB1 and hypercholesterolemia. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T05:58:51Z (GMT). No. of bitstreams: 1 ntu-99-R97629030-1.pdf: 1295240 bytes, checksum: 665937facfa7f2bbed8e9ba26b03ac12 (MD5) Previous issue date: 2010 | en |
| dc.description.tableofcontents | Contents
口試委員會審定書 Acknowledgements I 中文摘要 II Abstract III Contents IV Figures VI Tables VII Chapter 1: Literature review 1 1.1 Fumonisins and Fumonisin B1 1 1.2 Physics and Chemical Character of Fumonisin 2 1.3 Toxicity of Fumonisns 3 1.4 Metabolism of Sphingolipid 5 1.5 Pollution of FB1 6 1. 6 Function and Metabolism of Cholesterol 7 1.6.1 Synthesis of cholesterol 8 1.6.2 Absorption of Cholesterol from Intestine 9 1.6.3 Lipoproteins and Their Metabolism 10 1.6.4 Intracellular Metabolism 14 1.6.5 Metabolism to Bile Acid 14 1.7 Mechanism of Hypercholesterolemia 15 1.8 Treatment of Hypercholesterolemia 15 1.8.1 Statins 16 1.8.2 Fibrates 17 1.8.3 Probucol 17 Chapter 2: Aim of this study 18 Chapter 3: Material and Methods 19 3.1 Chemical 19 3.2 Cell line and Culture conditions 19 3.3 Effect of Fumonisin B1 on Cholesterol in HepG2 cell line 20 3.4 Effect of Fumonisin B1 and Hypocholesterolemic Drugs on Cholesterol in HepG2 cell line 21 3.5 Cholesterol Extraction and Measurement 22 3.6 RNA Extraction 22 3.7 Reverse Transcription 23 3.8 Real-Time PCR 24 3.9 Sampling Feeds and Blood 25 3.10 Mycotoxin Examination 26 3.11 Statistical Analyses 26 Chapter 4: Result 27 4.1 Effect of Fumonisin B1 on Cholesterol in HepG2 cell line 27 4.2 Effect of Fumonisin B1 and Simvastatin on Cholesterol in HepG2 cell line 27 4.3 Effect of Fumonisin B1 and Probucol on Cholesterol in HepG2 cell line 28 4.4 Effect of Fumonisin B1 and Fenofibrate on Cholesterol in HepG2 cell line 29 4.5 The Expression of mRNA of HepG2 cell treated with FB1 29 4.6 The Expression of mRNA of HepG2 cell treated with FB1 and Simvastatin 30 4.7 The Field Evidence on the Link Between Dietary FB1 and Hypercholesterolemia Endemic in Swine Population 31 Chapter 5: Discussion 33 Chapter 6: Conclusion 41 References 42 | |
| dc.language.iso | en | |
| dc.subject | Probucol | zh_TW |
| dc.subject | 伏馬鐮孢毒素B1 | zh_TW |
| dc.subject | 串珠鐮刀菌屬 | zh_TW |
| dc.subject | 高膽固醇血症 | zh_TW |
| dc.subject | ACAT | zh_TW |
| dc.subject | Probucol | en |
| dc.subject | Fumonisin B1 | en |
| dc.subject | Hypercholesterolemia | en |
| dc.subject | HepG2 cell lin | en |
| dc.subject | ACAT | en |
| dc.title | 伏馬鐮孢毒素導致高膽固醇血症的機制 | zh_TW |
| dc.title | Mechanism of hypercholesterolemia Induced by Fumonisin B1 | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 98-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.coadvisor | 龐飛(Fei Pang),鄭謙仁(Chian-Ren Jeng) | |
| dc.contributor.oralexamcommittee | 張志成,劉涓 | |
| dc.subject.keyword | 伏馬鐮孢毒素B1,串珠鐮刀菌屬,高膽固醇血症,ACAT,Probucol, | zh_TW |
| dc.subject.keyword | Fumonisin B1,Hypercholesterolemia,HepG2 cell lin,ACAT,Probucol, | en |
| dc.relation.page | 69 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2010-08-17 | |
| dc.contributor.author-college | 獸醫專業學院 | zh_TW |
| dc.contributor.author-dept | 獸醫學研究所 | zh_TW |
| 顯示於系所單位： | 獸醫學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-99-1.pdf 未授權公開取用 | 1.26 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。